Concepedia

Zhengnian Li

ZL

Statistics

Publications

13

Citations

1.3K

H-Index

13

Active since

2013

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Stanford University

Dana-Farber/Harvard Cancer Center

Chinese Academy of Sciences

Zhengnian Li is an author at Dana-Farber Cancer Institute specializing in molecular biology, life sciences, and medicinal chemistry.

Publications per year

2013–2024

13

Publications

13

Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development

Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman et al. · Cell · 2020 · 371 citations · Full text

Engineering, Bioengineering, Biotechnology +2

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15

T.B. Faust, Hojong Yoon, Radosław P. Nowak et al. · Nature Chemical Biology · 2019 · 211 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Bruton tyrosine kinase degradation as a therapeutic strategy for cancer

Dennis Dobrovolsky, Eric S. Wang, Sara Morrow et al. · Blood · 2018 · 169 citations · Full text

Medicine, Cancer Biology, Oncology +13

Rewiring cancer drivers to activate apoptosis

Sai Gourisankar, A. Krokhotin, Wenzhi Ji et al. · Nature · 2023 · 162 citations · Full text

Life Sciences, Cancer Biology, Oncology +12

Development and Characterization of a Wee1 Kinase Degrader

Zhengnian Li, Benika J. Pinch, Katherine A. Donovan et al. · Cell chemical biology · 2019 · 103 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

1–5 of 13